Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Genesis Healthcare, Inc. (SKH)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genesis Healthcare, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Genesis Healthcare, Inc. since 2005.
The reporting company's ticker symbol is SKH. The reporting company's CIK number is 1351051.
The total value of stock buying since 2005 is $26,739,523,709.
The total value of stock sales since 2005 is $7,722,677.
The total value of stock option exercises since 2005 is $0.
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-11 | 0 | $0 | 2,165,340 | $2,935,860 | 0 | $0 |
| 2018-10 | 0 | $0 | 10,917 | $17,860 | 0 | $0 |
| 2018-09 | 0 | $0 | 24,800 | $41,911 | 0 | $0 |
| 2018-08 | 0 | $0 | 352,733 | $601,040 | 0 | $0 |
| 2018-06 | 0 | $0 | 57,704 | $128,228 | 0 | $0 |
| 2017-06 | 0 | $0 | 46,969 | $79,591 | 0 | $0 |
| 2016-08 | 0 | $0 | 10,000 | $23,840 | 0 | $0 |
| 2016-06 | 0 | $0 | 21,730 | $37,436 | 0 | $0 |
| 2015-11 | 73,200 | $324,574 | 0 | $0 | 0 | $0 |
| 2015-02 | 0 | $0 | 0 | $0 | 247,499 | $0 |
| 2015-01 | 0 | $0 | 0 | $0 | 16,096 | $0 |
| 2014-01 | 0 | $0 | 0 | $0 | 14,388 | $0 |
| 2013-11 | 0 | $0 | 48,774 | $245,479 | 0 | $0 |
| 2013-08 | 0 | $0 | 80,746 | $525,949 | 0 | $0 |
| 2013-07 | 0 | $0 | 104,988 | $679,851 | 0 | $0 |
| 2013-01 | 0 | $0 | 0 | $0 | 17,272 | $0 |
| 2012-11 | 0 | $0 | 1,567 | $12,536 | 0 | $0 |
| 2012-08 | 0 | $0 | 0 | $0 | 14,336 | $0 |
| 2012-05 | 0 | $0 | 40,000 | $324,520 | 30,272 | $0 |
| 2012-02 | 0 | $0 | 34,303 | $236,930 | 0 | $0 |
| 2011-11 | 0 | $0 | 0 | $0 | 15,936 | $0 |
| 2011-08 | 390,500 | $1,777,818 | 0 | $0 | 0 | $0 |
| 2010-12 | 0 | $0 | 1,400 | $11,200 | 0 | $0 |
| 2010-11 | 1,060,500 | $5,524,295 | 0 | $0 | 0 | $0 |
| 2010-08 | 0 | $0 | 0 | $0 | 24,502 | $0 |
| 2010-05 | 147,843 | $26,731,439,851 | 0 | $0 | 0 | $0 |
| 2009-08 | 48,315 | $330,371 | 0 | $0 | 0 | $0 |
| 2009-05 | 0 | $0 | 19,484 | $174,010 | 0 | $0 |
| 2008-08 | 0 | $0 | 10,836 | $174,796 | 0 | $0 |
| 2008-02 | 10,000 | $126,800 | 0 | $0 | 0 | $0 |
| 2007-11 | 0 | $0 | 16,780 | $255,727 | 0 | $0 |
| 2007-05 | 0 | $0 | 78,446 | $1,215,913 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-11-27 | Reis David A (Director) | Sale | 2,000,000 | 1.33 | 2,660,000 |
| 2018-11-16 | Reis David A (Director) | Sale | 108 | 1.63 | 176 |
| 2018-11-15 | Reis David A (Director) | Sale | 5,089 | 1.64 | 8,320 |
| 2018-11-14 | Reis David A (Director) | Sale | 13,500 | 1.66 | 22,410 |
| 2018-11-13 | Reis David A (Director) | Sale | 17,861 | 1.70 | 30,363 |
| 2018-11-12 | Reis David A (Director) | Sale | 17,063 | 1.70 | 28,938 |
| 2018-11-09 | Reis David A (Director) | Sale | 26,096 | 1.67 | 43,580 |
| 2018-11-08 | Reis David A (Director) | Sale | 29,050 | 1.66 | 48,281 |
| 2018-11-07 | Reis David A (Director) | Sale | 25,970 | 1.68 | 43,629 |
| 2018-11-06 | Reis David A (Director) | Sale | 8,007 | 1.64 | 13,131 |
| 2018-11-05 | Reis David A (Director) | Sale | 3,140 | 1.63 | 5,121 |
| 2018-11-02 | Reis David A (Director) | Sale | 13,280 | 1.64 | 21,752 |
| 2018-11-01 | Reis David A (Director) | Sale | 6,176 | 1.65 | 10,159 |
| 2018-10-29 | Reis David A (Director) | Sale | 7,415 | 1.64 | 12,145 |
| 2018-10-10 | Reis David A (Director) | Sale | 3,502 | 1.63 | 5,715 |
| 2018-09-05 | Reis David A (Director) | Sale | 900 | 1.64 | 1,473 |
| 2018-09-04 | Reis David A (Director) | Sale | 23,900 | 1.69 | 40,438 |
| 2018-08-31 | Reis David A (Director) | Sale | 23,855 | 1.78 | 42,485 |
| 2018-08-30 | Reis David A (Director) | Sale | 20,920 | 1.76 | 36,923 |
| 2018-08-29 | Reis David A (Director) | Sale | 24,055 | 1.73 | 41,494 |
| 2018-08-28 | Reis David A (Director) | Sale | 25,768 | 1.70 | 43,676 |
| 2018-08-27 | Reis David A (Director) | Sale | 38,296 | 1.74 | 66,443 |
| 2018-08-24 | Reis David A (Director) | Sale | 51,419 | 1.71 | 87,875 |
| 2018-08-23 | Reis David A (Director) | Sale | 19,651 | 1.67 | 32,738 |
| 2018-08-14 | Reis David A (Director) | Sale | 2,249 | 1.63 | 3,665 |
| 2018-08-13 | Reis David A (Director) | Sale | 12,190 | 1.63 | 19,894 |
| 2018-08-10 | Reis David A (Director) | Sale | 32,926 | 1.65 | 54,459 |
| 2018-08-09 | Reis David A (Director) | Sale | 75,909 | 1.71 | 129,424 |
| 2018-08-08 | Reis David A (Director) | Sale | 25,495 | 1.65 | 41,964 |
| 2018-06-12 | Bach Paul David (COO) | Sale | 5,735 | 2.28 | 13,081 |
| 2018-06-12 | Reifsnyder Joanne Susan (EVP and Chief Nursing Officer) | Sale | 4,877 | 2.28 | 11,124 |
| 2018-06-12 | Sherman Michael Scott (SVP and General Counsel) | Sale | 3,516 | 2.28 | 8,019 |
| 2018-06-12 | Divittorio Thomas (SVP and CFO) | Sale | 5,899 | 2.28 | 13,455 |
| 2018-06-05 | Bach Paul David (COO) | Sale | 10,131 | 2.19 | 22,197 |
| 2018-06-05 | Reifsnyder Joanne Susan (EVP and Chief Nursing Officer) | Sale | 7,488 | 2.19 | 16,406 |
| 2018-06-05 | Sherman Michael Scott (SVP and General Counsel) | Sale | 5,797 | 2.19 | 12,701 |
| 2018-06-05 | Young Stephen Scott (SVP and Corporate Controller) | Sale | 4,857 | 2.19 | 10,641 |
| 2018-06-05 | Divittorio Thomas (SVP and CFO) | Sale | 9,404 | 2.19 | 20,604 |
| 2017-06-14 | Bach Paul David (COO) | Sale | 6,100 | 1.73 | 10,553 |
| 2017-06-14 | Reifsnyder Joanne Susan (EVP and Chief Nursing Officer) | Sale | 5,269 | 1.73 | 9,115 |
| 2017-06-14 | Sherman Michael Scott (SVP and General Counsel) | Sale | 3,903 | 1.73 | 6,752 |
| 2017-06-14 | Young Stephen Scott (VP and Corporate Controller) | Sale | 3,799 | 1.73 | 6,572 |
| 2017-06-14 | Hirschfeld Daniel Allen (COO Int'l. Oper. & Rehab Svcs.) | Sale | 7,245 | 1.73 | 12,533 |
| 2017-06-14 | Divittorio Thomas (SVP and CFO) | Sale | 6,341 | 1.73 | 10,969 |
| 2017-06-07 | Bach Paul David (COO) | Sale | 2,769 | 1.61 | 4,469 |
| 2017-06-07 | Reifsnyder Joanne Susan (EVP and Chief Nursing Officer) | Sale | 2,383 | 1.61 | 3,846 |
| 2017-06-07 | Sherman Michael Scott (SVP and General Counsel) | Sale | 1,824 | 1.61 | 2,943 |
| 2017-06-07 | Young Stephen Scott (VP and Corporate Controller) | Sale | 1,541 | 1.61 | 2,487 |
| 2017-06-07 | Hirschfeld Daniel Allen (COO Int'l. Oper. & Rehab Svcs.) | Sale | 2,895 | 1.61 | 4,672 |
| 2017-06-07 | Divittorio Thomas (SVP and CFO) | Sale | 2,900 | 1.61 | 4,680 |
| 2016-08-29 | Young Stephen Scott (VP and Corporate Controller) | Sale | 10,000 | 2.38 | 23,840 |
| 2016-06-08 | Reifsnyder Joanne Susan (EVP and Chief Nursing Officer) | Sale | 2,207 | 1.72 | 3,802 |
| 2016-06-08 | Sherman Michael Scott (SVP and General Counsel) | Sale | 1,919 | 1.72 | 3,306 |
| 2016-06-08 | Young Stephen Scott (VP and Corporate Controller) | Sale | 1,621 | 1.72 | 2,792 |
| 2016-06-08 | Hirschfeld Daniel Allen (COO Int'l. Oper. & Rehab Svcs.) | Sale | 3,009 | 1.72 | 5,184 |
| 2016-06-08 | Divittorio Thomas (SVP and CFO) | Sale | 3,051 | 1.72 | 5,256 |
| 2016-06-08 | Reitz Robert A (EVP and COO) | Sale | 3,892 | 1.72 | 6,705 |
| 2016-06-08 | Hager George V Jr (CEO) | Sale | 6,031 | 1.72 | 10,391 |
| 2015-11-19 | Whitman Arnold M (Director) | Buy | 43,200 | 4.54 | 196,214 |
| 2015-11-12 | Mckeon James V (Director) | Buy | 10,000 | 4.15 | 41,500 |
| 2015-11-11 | Divittorio Thomas (SVP & CFO) | Buy | 20,000 | 4.34 | 86,860 |
| 2015-02-02 | Yarwood Bruce A (Director) | Option Ex | 13,245 | .00 | 0 |
| 2015-02-02 | Rosenstock Linda (Director) | Option Ex | 74,001 | .00 | 0 |
| 2015-02-02 | Boxer Michael (Director) | Option Ex | 74,001 | .00 | 0 |
| 2015-02-02 | Puckett M Bernard (Director) | Option Ex | 86,252 | .00 | 0 |
| 2015-01-01 | Yarwood Bruce A (Director) | Option Ex | 16,096 | .00 | 0 |
| 2014-01-01 | Yarwood Bruce A (Director) | Option Ex | 14,388 | .00 | 0 |
| 2013-11-14 | Hendrickson Boyd W (CEO) | Sale | 45,974 | 5.04 | 231,479 |
| 2013-11-13 | Hendrickson Boyd W (CEO) | Sale | 2,800 | 5.00 | 14,000 |
| 2013-08-06 | Hendrickson Boyd W (CEO) | Sale | 4,983 | 6.01 | 29,952 |
| 2013-08-05 | Hendrickson Boyd W (CEO) | Sale | 20,417 | 6.44 | 131,485 |
| 2013-08-02 | Hendrickson Boyd W (CEO) | Sale | 10,000 | 6.56 | 65,569 |
| 2013-08-01 | Hendrickson Boyd W (CEO) | Sale | 39,600 | 6.60 | 261,399 |
| 2013-07-02 | Hendrickson Boyd W (CEO) | Sale | 29,900 | 6.37 | 190,044 |
| 2013-07-01 | Hendrickson Boyd W (CEO) | Sale | 45,100 | 6.54 | 295,950 |
| 2013-01-01 | Yarwood Bruce A (Director) | Option Ex | 17,272 | .00 | 0 |
| 2012-11-01 | Hendrickson Boyd W (CEO) | Sale | 1,567 | 8.00 | 12,536 |
| 2012-08-02 | Scott William (Director) | Option Ex | 14,336 | .00 | 0 |
| 2012-05-14 | Stephens Michael D (Director) | Option Ex | 30,272 | .00 | 0 |
| 2012-05-02 | Hendrickson Boyd W (CEO) | Sale | 40,000 | 8.11 | 324,520 |
| 2012-02-29 | Thomas Laurie (President Hallmark) | Sale | 6,450 | 6.60 | 42,589 |
| 2012-02-17 | Lynch Jose (President) | Sale | 7,853 | 6.90 | 54,201 |
| 2012-02-16 | Hendrickson Boyd W (CEO) | Sale | 20,000 | 7.01 | 140,140 |
| 2011-11-03 | Scott William (Director) | Option Ex | 15,936 | .00 | 0 |
| 2011-08-10 | Peck D. Shane (President Hospice and Homecare) | Buy | 10,000 | 4.25 | 42,500 |
| 2011-08-09 | Scott William (Director) | Buy | 200,000 | 4.60 | 914,074 |
| 2011-08-09 | Felfe Chris (SVP Finance, CAO) | Buy | 2,500 | 4.70 | 11,747 |
| 2011-08-08 | Monks Jonathan R. (SVP, Hospice and Homecare) | Buy | 10,000 | 4.53 | 45,250 |
| 2011-08-08 | Rapp Roland (General Counsel, CAO and Sec.) | Buy | 5,500 | 4.55 | 25,025 |
| 2011-08-05 | Peck D. Shane (President Hospice and Homecare) | Buy | 10,000 | 4.70 | 47,000 |
| 2011-08-05 | Rapp Roland (General Counsel, CAO and Sec.) | Buy | 3,800 | 4.66 | 17,719 |
| 2010-12-15 | Hendrickson Boyd W (CEO) | Sale | 1,400 | 8.00 | 11,200 |
| 2010-11-17 | Monks Jonathan R. (SVP, Hospice and Homecare) | Buy | 3,000 | 6.34 | 19,035 |
| 2010-11-09 | Monks Jonathan R. (SVP, Hospice and Homecare) | Buy | 5,000 | 6.00 | 30,000 |
| 2010-11-05 | Peck D. Shane (President Hospice and Homecare) | Buy | 15,000 | 5.35 | 80,250 |
| 2010-11-05 | Scott William (Director) | Buy | 314,373 | 5.19 | 1,630,965 |
| 2010-11-04 | Peck D. Shane (President Hospice and Homecare) | Buy | 5,000 | 5.55 | 27,765 |
| 2010-11-04 | Scott William (Director) | Buy | 285,627 | 5.19 | 1,483,545 |
| 2010-11-04 | Boxer Michael (Director) | Buy | 13,500 | 5.46 | 73,737 |
| 2010-08-06 | Stephens Michael D (Director) | Option Ex | 12,251 | .00 | 0 |
| 2010-08-06 | Scott William (Director) | Option Ex | 12,251 | .00 | 0 |
| 2010-05-12 | Monks Jonathan R. (SVP, Hospice and Homecare) | Buy | 53,905 | 7.58 | 408,761 |
| 2010-05-11 | Monks Jonathan R. (SVP, Hospice and Homecare) | Buy | 41,788 | 639,674.00 | 26,730,697,112 |
| 2010-05-07 | Peck D. Shane (President Hospice and Homecare) | Buy | 50,000 | 6.38 | 319,250 |
| 2010-05-07 | Rapp Roland (General Counsel, CAO and Sec.) | Buy | 150 | 6.79 | 1,018 |
| 2010-05-06 | Rapp Roland (General Counsel, CAO and Sec.) | Buy | 2,000 | 6.86 | 13,710 |
| 2009-08-07 | Hendrickson Boyd W (CEO) | Buy | 8,500 | 6.60 | 56,100 |
| 2009-08-06 | Gill Kelly J. (Executive Vice President) | Buy | 3,865 | 6.98 | 26,966 |
| 2009-08-06 | Lynch Jose (President) | Buy | 14,450 | 6.92 | 100,022 |
| 2009-08-06 | Rapp Roland (General Counsel, CAO and Sec.) | Buy | 10,000 | 6.76 | 67,600 |
| 2009-08-06 | Hendrickson Boyd W (CEO) | Buy | 11,500 | 6.93 | 79,683 |
| 2009-05-22 | Atkins Kelly (Sr VP Operations, Pacific) | Sale | 16,473 | 8.70 | 143,380 |
| 2009-05-11 | Moore Matt (Sr. VP of Operations, Midwest) | Sale | 3,011 | 10.17 | 30,630 |
| 2008-08-29 | Rapp Roland (General Counsel, CAO and Sec.) | Sale | 5,836 | 16.07 | 93,796 |
| 2008-08-19 | Miller John M V (Director) | Sale | 5,000 | 16.20 | 81,000 |
| 2008-02-15 | King John E (Treasurer and CFO) | Buy | 10,000 | 12.68 | 126,800 |
| 2007-11-30 | Parades Eddie (Sr. VP of Operations, Central) | Sale | 16,780 | 15.24 | 255,727 |
| 2007-05-18 | Lynch Jose (President and COO) | Sale | 70,800 | 15.50 | 1,097,400 |
| 2007-05-18 | Boxer Michael (Director) | Sale | 7,646 | 15.50 | 118,513 |
Insider trading activities including stock purchases, stock sales, and option exercises of SKH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genesis Healthcare, Inc. (symbol SKH, CIK number 1351051) see the Securities and Exchange Commission (SEC) website.